About Aditx Therapeutics
Aditx Therapeutics is a company based in Loma Linda (United States) founded in 2017.. Aditx Therapeutics has raised $109.8 thousand across 4 funding rounds. The company has 26 employees as of December 31, 2024. Aditx Therapeutics has completed 4 acquisitions, including AiPharma, Aipharma and Appili Therapeutics. Aditx Therapeutics offers products and services including Adimune, Pearsanta, Adivue, Appili, and Evofem. Aditx Therapeutics operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
- Headquarter Loma Linda, United States
- Employees 26 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aditxt, Inc.
-
Annual Revenue
$133.99 K-79.23as on Dec 31, 2024
-
Net Profit
$-34.45 M-6.38as on Dec 31, 2024
-
EBITDA
$-27.25 M-6.77as on Dec 31, 2024
-
Total Equity Funding
$109.8 K (USD)
in 4 rounds
-
Latest Funding Round
$6 M (USD), Post-IPO
Dec 29, 2023
-
Investors
-
Employee Count
26
as on Dec 31, 2024
-
Investments & Acquisitions
AiPharma
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aditx Therapeutics
Aditx Therapeutics is a publicly listed company on the NASDAQ with ticker symbol ADTX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aditx Therapeutics
Aditx Therapeutics offers a comprehensive portfolio of products and services, including Adimune, Pearsanta, Adivue, Appili, and Evofem. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Focuses on addressing autoimmunity issues through innovative health solutions.
Develops tools for early cancer detection in health diagnostics.
Targets neurological conditions with diagnostic innovations.
Plans programs for managing infectious disease challenges.
Focuses on reproductive health innovations and treatments.
Unlock access to complete
Unlock access to complete
Funding Insights of Aditx Therapeutics
Aditx Therapeutics has successfully raised a total of $109.8K across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $6.0M
-
First Round
First Round
(24 Dec 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Post-IPO - Aditx Therapeutics | Valuation |
investors |
|
| Sep, 2023 | Amount | Post-IPO - Aditx Therapeutics | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Aditx Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Aditx Therapeutics
Aditx Therapeutics has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include AiPharma, Aipharma and Appili Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Distributor of diversified pharmaceutical products
|
2021 | ||||
|
Pharmaceutical drugs are manufactured by AiPharma in Dubai.
|
2020 | ||||
|
Developer of drugs to treat infectious diseases
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Aditx Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aditx Therapeutics Comparisons
Competitors of Aditx Therapeutics
Aditx Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aditx Therapeutics
Frequently Asked Questions about Aditx Therapeutics
When was Aditx Therapeutics founded?
Aditx Therapeutics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Aditx Therapeutics located?
Aditx Therapeutics is headquartered in Loma Linda, United States. It is registered at Loma Linda, California, United States.
Is Aditx Therapeutics a funded company?
Aditx Therapeutics is a funded company, having raised a total of $109.8K across 4 funding rounds to date. The company's 1st funding round was a Post-IPO of $6M, raised on Dec 24, 2018.
How many employees does Aditx Therapeutics have?
As of Dec 31, 2024, the latest employee count at Aditx Therapeutics is 26.
What is the annual revenue of Aditx Therapeutics?
Annual revenue of Aditx Therapeutics is $133.99K as on Dec 31, 2024.
What does Aditx Therapeutics do?
Aditx Therapeutics was founded in 2017 and is based in Loma Linda, United States. Operations focus on the biotechnology sector, where a technology platform is commercialized to deliver personalized profiles of the immune system. Immune monitoring solutions are supplied to the medical community, with the AditxtScore product developed specifically for Covid-19 applications. The companys domain is aditxt.com, and key personnel include Amro Albanna.
Who are the top competitors of Aditx Therapeutics?
Aditx Therapeutics's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Aditx Therapeutics offer?
Aditx Therapeutics offers Adimune, Pearsanta, Adivue, Appili, and Evofem.
Is Aditx Therapeutics publicly traded?
Yes, Aditx Therapeutics is publicly traded on NASDAQ under the ticker symbol ADTX.
How many acquisitions has Aditx Therapeutics made?
Aditx Therapeutics has made 4 acquisitions, including AiPharma, Aipharma, and Appili Therapeutics.
What is Aditx Therapeutics's ticker symbol?
The ticker symbol of Aditx Therapeutics is ADTX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.